No surgeon has ever transplanted a human brain, and the procedure remains far beyond current medical capability. The obstacles are not merely technical but biological: reconnecting a severed spinal cord, preserving billions of neurons during transfer, suppressing immune rejection inside the skull, and restoring the autonomic signals that keep a body’s heart beating and blood pressure stable. Researchers have pursued pieces of this puzzle in animal models for over a century, but the full problem is orders of magnitude harder than any transplant medicine has achieved so far.
Brain Transplant Versus Head Transplant
When people ask about brain transplants, they usually picture removing a brain from one skull and placing it into another. In practice, though, nearly all serious scientific proposals have focused on head transplantation instead, sometimes called “cephalosomatic anastomosis” or “body-to-head transplant.” The reason is straightforward: the brain does not sit in the skull like a kidney sits in the abdomen. It is wired into the cranial nerves that control your eyes, your facial muscles, your hearing, your sense of smell, and your ability to swallow. Removing the brain from its skull would sever all of those connections simultaneously, and most of them run through the central nervous system, where regrowth is extremely limited. Optic nerve axons, for example, have almost no regenerative capacity because of the inhibitory environment inside the central nervous system, and they would need to reconnect with precise routing to both sides of the visual pathway to restore sight.1PubMed Central. Optic Nerve Regeneration: Potential Treatment Approaches
By keeping the brain inside the skull and transplanting the entire head onto a new body, you preserve those cranial nerve connections. The problem shrinks from “reconnect everything” to “reconnect the spinal cord and blood supply,” which is still an enormous challenge but at least a conceptually tractable one. This is why the scientific literature overwhelmingly discusses head transplantation when exploring this territory, and why the rest of this article follows that framing.
A Century of Animal Experiments
The idea is older than most people realize. In 1908, Alexis Carrel and Charles Guthrie performed the first dog head transplant, grafting one dog’s head onto another dog’s neck and connecting the arteries so blood flowed through both heads. The transplanted head had been without blood flow for about 20 minutes. It showed some reflex movements early on but deteriorated quickly, and the animal was euthanized within hours.2PubMed Central. The history of head transplantation: a review
Nearly half a century later, in 1954, the Soviet surgeon Vladimir Demikhov tried a similar procedure with dogs and achieved somewhat better results. His transplanted heads could move, see, and even lap up water. Then in 1970, the American neurosurgeon Robert White performed the first head transplant in primates, connecting isolated monkey heads to isolated monkey bodies by suturing the carotid arteries and jugular veins directly. Within a few hours after surgery, the transplanted heads could chew, swallow food, track objects with their eyes, and bite when stimulated.2PubMed Central. The history of head transplantation: a review
White’s monkeys, however, were paralyzed from the neck down. He made no attempt to reconnect the spinal cord, and the animals survived only a matter of days before immune rejection overwhelmed them. These experiments demonstrated that a brain could survive being moved to a new body, at least briefly, but they also exposed the two towering problems that remain unsolved: spinal cord fusion and immune control.
Why the Spinal Cord Is the Central Barrier
Every transplant surgery involves reconnecting tissues, but the spinal cord is in a category of its own. When spinal cord tissue is cut, a cascade of destructive processes follows: axons degenerate, neurons die, inflammation flares, and specialized cells called astrocytes form a dense scar border. That scar is a physical and chemical wall made up of elongated cells and inhibitory molecules that block regenerating nerve fibers from growing across the gap.3PubMed Central. Current Advancements in Spinal Cord Injury Research-Glial Scar Formation and Neural Regeneration The scar actually serves a protective purpose by containing the damage, but it also makes repair extraordinarily difficult.
Peripheral nerves, like those in your arms and legs, can regrow after injury because their environment actively supports it. The central nervous system works in the opposite direction, actively suppressing regrowth. This is the fundamental reason why spinal cord injuries cause permanent paralysis in most cases, and it is the same reason a head transplant would leave the recipient unable to move, breathe independently, or feel anything below the neck unless that cord could somehow be fused.
The most publicized attempt to solve this problem has been the GEMINI protocol, proposed by the Italian neurosurgeon Sergio Canavero. The idea involves using polyethylene glycol (PEG), a chemical fusogen, applied directly to the cleanly cut ends of the spinal cord. PEG can repair damaged cell membranes, reduce oxidative stress, and promote some degree of axonal regrowth in animal models.4PubMed Central. Polyethylene glycol in spinal cord injury repair: a critical review In one rat experiment using a modified version of PEG combined with graphene nanoribbons, researchers reported some neurophysiological recovery after sharp cervical cord transection.5PubMed Central. Spinal cord fusion with PEG-GNRs (TexasPEG): Neurophysiological recovery in 24 hours in rats
Those results sound promising until you consider the scale of the problem. A rat spinal cord is tiny and simple compared to a human one. Recovering some electrical signals across a clean cut in a rat is a far cry from restoring voluntary motor control, sensation, and autonomic function across a complete human spinal cord transection. No experiment in any animal has demonstrated the kind of functional spinal cord fusion that a head transplant would require.
Keeping the Brain Alive During Transfer
Even setting aside spinal cord reconnection, simply keeping the brain alive while moving it from one body to another is a formidable challenge. The brain is metabolically voracious: it accounts for roughly 2 percent of body weight but consumes about 20 percent of the body’s oxygen. Interrupt its blood supply for more than a few minutes and neurons start dying in waves.
More recent mouse experiments have tried to address this by maintaining blood flow throughout the procedure. Researchers established a cross-circulation system between the donor and recipient, cannulating and connecting the carotid artery on one side and the jugular vein on the other, so the transplanted head never lost perfusion. Electroencephalogram recordings and intact cranial nerve reflexes confirmed that neurological function was preserved during the surgery.6PubMed Central. Head Transplantation in Mouse Model That’s an important step, but it was demonstrated in mice over short time frames, and the leap to human-scale anatomy, with its longer vessels and larger blood volumes, introduces complications that have not been tested.
Therapeutic hypothermia, cooling the brain to slow its metabolism, is one strategy that could buy time during the transfer window. Cooling reduces the brain’s demand for oxygen and slows down multiple harmful processes that kick in during ischemia, including excitotoxicity, inflammation, free radical damage, and cell death pathways.7Nature Reviews Neuroscience. Neuroprotective mechanisms of hypothermia in brain ischaemia Hypothermia is already used in cardiac surgery and after cardiac arrest to protect the brain, so the principle is well established. Whether it could provide enough protection for the extended duration a head transplant would require is another question entirely.
The Immune System Inside the Skull
The brain was long considered “immune privileged,” meaning the body’s immune defenses could not easily reach it. The blood-brain barrier, a tight seal of endothelial cells lining the brain’s blood vessels, blocks many immune cells and antibodies from crossing into brain tissue. In theory, this could work in a transplant’s favor: the donor brain might be partially shielded from the recipient’s immune attack.
In practice, the picture is much less reassuring. The blood-brain barrier’s integrity depends on it remaining uninjured. Ischemia, which is essentially unavoidable during a transplant, damages the barrier and makes it permeable. Once breached, immune cells can enter the brain, and donor-derived microglial precursors from the bone marrow could cross through the site of injury and initiate rejection damage from the inside.8International Journal of Surgery. The immunologic considerations in human head transplantation
Animal studies have shown that immune responses to transplanted neural tissue vary dramatically depending on where in the brain the graft is placed. In one study, neural precursor cell grafts in the striatum were heavily infiltrated by immune cells and completely rejected, while grafts in the hippocampus experienced a milder immune response and survived for at least two months.9PubMed Central. Brain Region-Dependent Rejection of Neural Precursor Cell Transplants A whole-brain transplant would expose every region simultaneously, and the regions most vulnerable to rejection would set the pace. Standard anti-rejection drugs used for organ transplants suppress the immune system broadly, but the brain’s unique vulnerability to infection and inflammation makes aggressive immunosuppression risky.
Autonomic Collapse Below the Cut
There is a problem that tends to get overlooked in popular discussions of head transplants: even if you could reconnect voluntary movement, you would still need the autonomic nervous system to work. This is the part of the nervous system that controls your heart rate, blood pressure, digestion, bladder function, temperature regulation, and breathing without you thinking about it. Much of this signaling runs through the spinal cord, and severing it disrupts all of it.
People living with high-level spinal cord injuries already face these problems. Research on individuals with cervical and upper thoracic injuries has documented significantly reduced heart rate variability, abnormal blood pressure regulation, loss of the normal nighttime blood pressure dip, and a dangerous condition called autonomic dysreflexia, where stimuli below the injury trigger spikes in blood pressure that the body cannot control.10PubMed Central. Cardiovascular autonomic function in middle-aged people with long-term cervical and upper thoracic spinal cord injuries In rat models of spinal cord transection, researchers have had to use implanted radio transmitters just to monitor the cardiovascular instability that follows, and grafting embryonic neural stem cells into the injury site is being explored as one way to partially restore autonomic pathways.11PubMed Central. A radio-telemetric system to monitor cardiovascular function in rats with spinal cord transection and embryonic neural stem cell grafts
A head transplant recipient would face all of these autonomic disruptions, potentially more severely because the cut would be at the highest cervical level. The donor body’s heart would need to keep beating, the lungs would need to keep expanding, and blood pressure would need to stay within a survivable range, all while the brain’s connection to those systems was severed and, at best, gradually being rebuilt. Managing this in the immediate postoperative period would be a life-support challenge of extraordinary complexity.
Chronic Pain After Spinal Cord Transection
Even in a best-case scenario where the recipient survived and achieved some degree of recovery, chronic neuropathic pain would be a serious concern. Between 10 and 20 percent of spinal cord injury patients develop central neuropathic pain, a severe type of chronic pain caused by abnormal activity in the neurons above and around the injury site rather than by any ongoing tissue damage.12PubMed. Pathophysiological mechanisms of central neuropathic pain after spinal cord injury This pain is notoriously resistant to treatment. Standard painkillers are mostly ineffective, and the underlying mechanisms involve changes in how neurons fire, including increased excitatory activity, altered sodium channels, and loss of the brain’s normal inhibitory controls over pain signaling.
In rat experiments, complete spinal cord transection produced dramatic hypersensitivity in the skin just above the injury, with pain thresholds dropping to one-hundredth of normal levels. This allodynia, where normally harmless touch becomes painful, persisted for at least two months and was accompanied by widespread inflammation and glial cell activation in the spinal cord and nerve roots near the injury.13PubMed Central. Spinal cord transection-induced allodynia in rats–behavioral, physiopathological and pharmacological characterization Only a few drugs, including ketamine and morphine, provided any relief in these models, while several commonly prescribed neuropathic pain medications were ineffective.
Research on the pain generators in human spinal cord injury patients has found that the dorsal root entry zone below the level of complete transection can itself become a primary source of central pain, transmitting signals to the brain through sympathetic nervous system pathways rather than through the normal sensory tracts.14PubMed. Spinal cord injury below-level neuropathic pain relief with dorsal root entry zone microcoagulation performed caudal to level of complete spinal cord transection A head transplant recipient would essentially be a person with a surgically created complete spinal cord injury, facing all of these pain risks on top of everything else.
Scaffolds, Stem Cells, and the Long Road to Spinal Repair
Researchers are pursuing multiple strategies to promote spinal cord regeneration, though none is close to enabling a head transplant. One promising approach combines biomaterial scaffolds with stem cells. The scaffold acts as a physical bridge across the injury gap, providing a surface along which regrowing axons can travel, while stem cells seeded into the scaffold can release growth-promoting molecules and potentially replace lost neurons and supporting cells. Both neural stem cells and mesenchymal stem cells have been tested in these combination systems, and natural and synthetic biomaterials have improved stem cell survival compared to injecting cells alone.15PubMed Central. Repair of injured spinal cord using biomaterial scaffolds and stem cells
These scaffold-and-cell approaches represent genuine progress in spinal cord injury research, but the functional recovery demonstrated so far in animals is modest: partial improvements in movement, some regrowth of axons across short gaps. The gap between “some axons grew a few millimeters through a scaffold in a rat” and “a human can walk and breathe after their spinal cord was completely transected” is vast. The spinal cord carries millions of nerve fibers organized in precise bundles, and restoring function requires not just that axons grow but that they find the right targets and form the right connections. Random regrowth across a junction would be more likely to produce garbled signals than coordinated movement.
The Resource Allocation Problem
Even if the technical barriers were overcome, a head transplant would face a stark ethical challenge around resource use. A single donor body used for a head transplant could save far more lives if its organs were donated individually. One estimate puts the number at 10 to 15 lives that could be saved or significantly improved through multiple organ and tissue donations from the same body, including the heart, lungs, liver, kidneys, pancreas, intestines, corneas, bone, tendons, skin, and heart valves.16International Journal of Surgery. Surgical, ethical, and psychosocial considerations in human head transplantation Using that body for a single experimental procedure with uncertain outcomes, while patients on organ waiting lists die, raises serious questions about distributive justice.
The legal and ethical questions extend further. Whose identity does the surviving person have: the head donor’s or the body donor’s? Who inherits property, maintains marriages, or bears legal responsibility? Existing legal frameworks for organ transplantation were not designed for a procedure that transplants the seat of consciousness, and bioethicists have flagged numerous unresolved issues around consent, human subjects research protections, and the legal consequences for any surgeon who attempts the procedure.17PubMed Central. Body -to-head transplant; a “caputal” crime? Examining the corpus of ethical and legal issues
Neuroprosthetics as an Alternative Path
While full head transplantation remains in the realm of speculation, the technologies that would make it worthwhile, specifically restoring function to people with paralysis, severe neurological disease, or lost sensory capacity, are advancing through a different route entirely. Neuroprostheses are electronic systems that bridge or bypass damaged neural pathways, and they have become a genuinely transformative technology for restoring sensory, motor, and cognitive functions in people with neurological disorders.18PubMed Central. Advances in neuroprostheses: interfaces, materials, and applications
Brain-computer interfaces now allow paralyzed individuals to control robotic arms, type on screens, and even move their own limbs through implanted stimulators that bypass the spinal cord injury. Cochlear implants have been restoring hearing for decades. Retinal implants are in clinical trials. These devices do not require severing a spinal cord and hoping it fuses back together; they work around the damage that already exists. For many of the patients who might theoretically benefit from a head transplant, people with progressive neuromuscular disease, for instance, or severe spinal cord injuries, neuroprosthetics offer a path toward restored function that is grounded in working technology rather than speculative surgery.
The irony is that some of the same advances driving neuroprosthetics forward, like our improving understanding of how neurons communicate and how to interface electronics with living tissue, are also the kinds of breakthroughs that would be needed to make spinal cord fusion plausible. But for now, the electronic bypass route is decades ahead of the biological fusion route, and it carries dramatically less risk. A brain-computer interface implant, while still experimental, does not require a donor body, does not sever an intact spinal cord, and does not gamble a patient’s entire nervous system on an untested procedure. For anyone genuinely hoping to see paralysis conquered in their lifetime, the prosthetics lab is where the most credible progress is happening.